TRISTAN ORPIN
CIK 1215631 · EVP Clinical Genomics · last filed 2016-11-08
TRISTAN ORPIN is an EVP Clinical Genomics who has filed 107 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing shows the insider had shares withheld for taxes covering $95.5K of ILMN on Nov 8, 2016. Across all open-market trades the lifetime net is −$31.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$20.71M
1
107
-$31.29M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ILMN | EVP Clinical Genomics | 118,259 | $175.09 | $20.71M | -$31.29M | 107 | 2016-11-08 |
Recent Filings
107 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-11-08 | ILMN | Tax (F) | −697 | -$95.5K | EDGAR |
| 2016-03-09 | ILMN | Tax (F) | −685 | -$103.0K | EDGAR |
| 2016-03-07 | ILMN | Mixed | +17,844 | -$2.86M | EDGAR |
| 2016-02-01 | ILMN | Tax (F) | −794 | -$125.4K | EDGAR |
| 2015-12-14 | ILMN | Grant (A) | +3,164 | $0 | EDGAR |
| 2013-07-11 | ILMN | Mixed | — | -$304.9K | EDGAR |
| 2013-06-27 | ILMN | Mixed | — | -$1.52M | EDGAR |
| 2013-06-17 | ILMN | Mixed | — | -$1.95M | EDGAR |
| 2013-05-14 | ILMN | Mixed | — | -$1.24M | EDGAR |
| 2013-05-09 | ILMN | Mixed | — | -$228.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.